If you could vote on Brexit now which option would you choose?

Moderna taps National Resilience's new Canadian manufacturing site for COVID-19 vaccine production duties

Fresh off National Resilience's acquisition of a new, state-of-the-art manufacturing site in Ontario, the fledgling CDMO is putting it to the test with a high-profile partnership. Moderna has tapped National Resilience, founded in November last year, to manufacture mRNA vaccine substance at Resilience’s newly acquired facility in Mississauga, Canada. While sparse on details, Moderna said the substance made at the plant will be delivered globally. The partnership marks Moderna’s most recent foray into Canada and comes as the biotech faces a vaccine contamination scandal in Japan. In late August, Japanese pharma Takeda, which distributes Moderna’s shot in the country, said it suspended three lots—or about 1.63 million doses—after finding tiny black specks in the vials.

FiercePharma - September 8, 2021

View the full story here: https://www.fiercepharma.com/pharma/moderna-taps-national-resilience-s-new-canadian-manufacturing-site-for-covid-19-vaccine